Biotech Incubators Cultivate a Global Scene

Publication
Article
BioPharm InternationalBioPharm International, Emerging Therapies September 2022
Volume 2022 eBook
Issue 3
Pages: 28–33

The growth of the biopharmaceuticals market is feeding back into economies and, in part, is driving the boom in life sciences and biotech ecosystems.

naka/Stock.adobe.com–global entities are investing heavily in growing their regional life sciences ecosystem

naka/Stock.adobe.com

The life sciences industry is seeing a robust trend in biotech incubator spaces geared toward fostering the growth of new and emerging biotech startups. Incubators on a global scale are determined to grow life sciences innovation in tandem with economically developing local regions. In the United States and other countries, life science sectors around the world are invigorated by efforts on the part of various entities—including government, industry, and academia. Working collectively, these entities aim to foster the growth of burgeoning regional biopharmaceutical industries by providing biotech startups space, talent, funding, and resources.

Read this article in BioPharm International’s September 2022 Emerging Therapies 2022 eBook.

About the author

Feliza Mirasol is the science editor for BioPharm International.

Article Details

BioPharm International
eBook: Emerging Therapies 2022, September 2022
September 2022
Pages: 28–33

Citation

When referring to this article, please cite it as F. Mirasol, “Biotech Incubators Cultivate a Global Scene," BioPharm International Emerging Therapies 2022 eBook (September 2022).

Articles in this issue
Treating Cancer with Oncolytic Viruses
Treating Cancer with Oncolytic Viruses
Accelerating the Development of mRNA Therapeutics
Accelerating the Development of mRNA Therapeutics
greenbutterfly/Stock.adobe.com—Document integrity is critical in the provision of raw materials for cell and gene therapy manufacturing.
Real-Time Post-Apheresis Documentation Decreases Errors
Likanaris/Stock.adobe.com—Using an orthogonal approach to lipid nanoparticle analysis can increase the odds of project success.
Shining a Light on Lipid Nanoparticle Characterization
The Road to Personalized Medicine: Reimagining Drug Manufacturing
The Road to Personalized Medicine: Reimagining Drug Manufacturing
Novel Therapies of 2022
Novel Therapies of 2022
naka/Stock.adobe.com–global entities are investing heavily in growing their regional life sciences ecosystem
Biotech Incubators Cultivate a Global Scene
Recent Videos
Preeya Beczek, managing director and co-founder of Beczek.COM, chats about industry trends from 2024 and which of those might impact the industry in 2025, including the big trend of AI.
Kate Coleman, vice president regulatory affairs, quality and compliance, Arriello, chats about industry trends and technological advances.
Related Content
Text sign showing Industry News. Business photo text delivering news to the general public or a target public | Image Credit: © Artur - stock.adobe.com

At INTERPHEX 2025, Culture Biosciences Launches Cloud-Integrated Mobile Bioreactor

Patrick Lavery
April 1st 2025
Article

The company said the Stratyx 250 is the first bioreactor of its kind to offer biotech companies a combination of automation, remote process control, and flexibility.

Podcast: Alternative Drug Delivery Methods for Biologics: Where Are We At?

Podcast: Alternative Drug Delivery Methods for Biologics: Where Are We At?

Feliza Mirasol
September 27th 2024
Podcast

This podcast explores the challenges of and the progress made so far by the biopharma industry toward alternative drug delivering methods for biologic drugs.

Science laboratory test tubes, laboratory equipment | Image Credit: © BillionPhotos.com - © BillionPhotos.com - stock.adobe.com

Novartis Grows Workforce and Opens New Viral Vector Manufacturing Facility in Slovenia on Back of Significant Investments

Feliza Mirasol
March 28th 2025
Article

Having completed its €40 million (US$43 million) investment in Slovenia, Novartis has opened its first specialized viral vector production facility in Europe, following earlier significant investments in R&D that has driven the growth of Slovenia’s workforce.

Drug Solutions Podcast: Considering Biologic Drug Development and Manufacturing Holistically

Drug Solutions Podcast: Considering Biologic Drug Development and Manufacturing Holistically

Felicity Thomas
May 25th 2023
Podcast

Hanns-Christian Mahler and Andrea Allmendinger from ten23 health will discuss some key aspects of biologic drug development and manufacturing.

Science laboratory test tubes, laboratory equipment | Image Credit: © BillionPhotos.com - © BillionPhotos.com - stock.adobe.com

British Patient Capital Invests £10 Million in Maxion Therapeutics, Part of Series A Financing Round

Feliza Mirasol
March 27th 2025
Article

The £10 million (US$13 million) investment is part of a larger £58 million (US$75 million) Series A financing round to be used for the development of Maxion Therapeutics’ preclinical lead program for treating inflammatory diseases.

Text sign showing Industry News. Business photo text delivering news to the general public or a target public | Image Credit: © Artur - © Artur - stock.adobe.com

EC Approves Imfinzi for Treatment of LS-SCLC

Feliza Mirasol
March 26th 2025
Article

The commission’s approval makes durvalumab the first and only immunotherapy for LS-SCLC in the EU.

© 2025 MJH Life Sciences

All rights reserved.